ConductScience.org, home

Paper68440

Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment.

Constantinides PG and 2 others. Nature, 1977. Cited by 281 papers, by iCite.

Cite this record

ConductScience Library. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Papers, record 68440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68440

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment.
PubMed
Journal
Nature
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
281
iCite
Relative citation ratio, by iCite
4.33
iCite
Revised in PubMed
2019-06-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Constantinides PGP G
2Jones PAP A
3Gevers WW

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzacitidineMajor topic
Cell DifferentiationMajor topic
MusclesMajor topic
Acetylcholine
Cell Line
Cell Survival
Dose-Response Relationship, Drug
Muscle Contraction
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by107

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.

PMIDTitleJournalYearIn PapersSource
41146328TET exhibits enzymatic-independent and-dependent functions during Drosophila flight muscle development and aging.Skelet Muscle2025https://conductscience.org/library/papers/41146328PubMed
40565684Fin Cells as a Promising Seed Cell Source for Sustainable Fish Meat Cultivation.Foods2025https://conductscience.org/library/papers/40565684PubMed
37854355The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia.Ther Adv Hematol2023https://conductscience.org/library/papers/37854355PubMed
37107631An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.Genes (Basel)2023https://conductscience.org/library/papers/37107631PubMed
37045940DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.Sci Rep2023https://conductscience.org/library/papers/37045940PubMed
36984613Mass Spectrometry Contribution to Pediatric Cancers Research.Medicina (Kaunas)2023https://conductscience.org/library/papers/36984613PubMed
36350512Pathways of DNA Demethylation.Adv Exp Med Biol2022https://conductscience.org/library/papers/36350512PubMed
35846373The Art of Reprogramming for Regenerative Medicine.Front Cell Dev Biol2022https://conductscience.org/library/papers/35846373PubMed
356723345-Azacytidine increases tanshinone production in Salvia miltiorrhiza hairy roots through epigenetic modulation.Sci Rep2022https://conductscience.org/library/papers/35672334PubMed
35393412Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges.NPJ Regen Med2022https://conductscience.org/library/papers/35393412PubMed
34790902Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.Nat Cancer2021https://conductscience.org/library/papers/34790902PubMed
34668236Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy.J Cell Biochem2022https://conductscience.org/library/papers/34668236PubMed
34510713Simple derivation of skeletal muscle from human pluripotent stem cells using temperature-sensitive Sendai virus vector.J Cell Mol Med2021https://conductscience.org/library/papers/34510713PubMed
33837369Transcriptional networks controlling stromal cell differentiation.Nat Rev Mol Cell Biol2021https://conductscience.org/library/papers/33837369PubMed
33796823Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia.Cancer Drug Resist2021https://conductscience.org/library/papers/33796823PubMed
33737730Skeletal muscle regeneration via the chemical induction and expansion of myogenic stem cells in situ or in vitro.Nat Biomed Eng2021https://conductscience.org/library/papers/33737730PubMed
33396941Molecular Mechanisms Regulating Muscle Plasticity in Fish.Animals (Basel)2020https://conductscience.org/library/papers/33396941PubMed
33299474Adding a dimension to cell fate.Anim Reprod2020https://conductscience.org/library/papers/33299474PubMed
31419653Engineered skeletal muscles for disease modeling and drug discovery.Biomaterials2019https://conductscience.org/library/papers/31419653PubMed
31301002Master control: transcriptional regulation of mammalian Myod.J Muscle Res Cell Motil2019https://conductscience.org/library/papers/31301002PubMed

See all 107 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/68440

GET https://conductscience.org/api/papers/v1/68440/cited_by?page=2